1. Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al.A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol 2020, 73:202-209.
https://doi.org/10.1016/j.jhep.2020.03.039.
2. Lee SJ, Kim SU.Noninvasive monitoring of hepatic steatosis: controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol 2019, 13:523-530.https://doi.org/10.1080/17474124.
2019.1608820.
3. Eslam M, Sanyal AJ, George J, on behalf of an International Consensus Panel.MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology 2020, 158:1999-2014 e1991.
https://doi.org/10.1053/j.gastro.2019.11.312.
4. Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2019, 4:389-398.https://doi.org/10.1016/s2468-1253(19)30039-1.
5. Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P, et al. Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology 2020, 71:1851-1864. https://doi.org/10.1002/hep.31150.
6. Sun DQ, Jin Y, Wang TY, Zheng KI, Rios RS, Zhang HY, et al.MAFLD and risk of CKD. Metabolism 2021, 115:154433.https://doi.org/10.1016/j.metabol.2020.
154433.
7. Lin S, Huang J, Wang M, Kumar R, Liu Y, Liu S,et al.Comparison of MAFLD and NAFLD diagnostic criteria in real world. Liver Int 2020, 40:2082-2089. https://doi.org/10.1111/liv.14548.
8. Younossi ZM.Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol 2019, 70:531-544.https://doi.org/10.1016/j.jhep.2018.
10.033.
9. Engin A.Non-Alcoholic Fatty Liver Disease. Adv Exp Med Biol 2017, 960:443-467. https://doi.org/10.1007/978-3-319-48382-5_19.
10. Gustafson B, Smith U.Regulation of white adipogenesis and its relation to ectopic fat accumulation and cardiovascular risk. Atherosclerosis 2015, 241:27-35. https://doi.org/10.1016/j.atherosclerosis.2015.04.812.
11. Almeida NS, Rocha R, Cotrim HP, Daltro C.Anthropometric indicators of visceral adiposity as predictors of non-alcoholic fatty liver disease: A review. World J Hepatol 2018, 10:695-701. https://doi.org/10.4254/wjh.v10.i10.695.
12. Motamed N, Rabiee B, Hemasi GR, Ajdarkosh H, Khonsari MR, Maadi M, et al.Body Roundness Index and Waist-to-Height Ratio are Strongly Associated With Non-Alcoholic Fatty Liver Disease: A Population-Based Study. Hepat Mon 2016, 16:e39575.https://doi.org/10.5812/hepatmon.39575.
13. Rotter I, Ryl A, Grzesiak K, Szylinska A, Pawlukowska W, Lubkowska A, et al.Cross-Sectional Inverse Associations of Obesity and Fat Accumulation Indicators with Testosterone in Non-Diabetic Aging Men. Int J Environ Res Public Health 2018, 15.https://doi.org/10.3390/ijerph15061207.
14. Verma M, Rajput M, Sahoo SS, Kaur N, Rohilla R.Correlation between the percentage of body fat and surrogate indices of obesity among adult population in rural block of Haryana. J Family Med Prim Care 2016, 5:154-159.
https://doi.org/10.4103/2249-4863.184642.
15. Jayedi A, Soltani S, Zargar MS, Khan TA, Shab-Bidar S.Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies. BMJ 2020, 370:m3324.https://doi.org/10.1136/
bmj.m3324.
16. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet 2004, 363:157-163. https://doi.org/10.1016/s0140-6736(03)15268-3.
17. Kahn HS.The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 2005, 5:26. https://doi.org/10.1186/1471-2261-5-26.
18. Peters SAE, Carcel C, Millett ERC, Woodward M.Sex differences in the association between major risk factors and the risk of stroke in the UK Biobank cohort study. Neurology 2020, 95:e2715-e2726.https://doi.org/10.1212/WNL.
0000000000010982.
19. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M,et al.Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 2010, 33:920-922. https://doi.org/10.2337/dc09-1825.
20. Bergman RN, Stefanovski D, Buchanan TA, Sumner AE, Reynolds JC, Sebring NG,et al.A better index of body adiposity. Obesity (Silver Spring) 2011, 19:1083-1089. https://doi.org/10.1038/oby.2011.38.
21. Roriz AK, Passos LC, de Oliveira CC, Eickemberg M, Moreira Pde A, Sampaio LR. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly. PLoS One 2014, 9:e103499.https://doi.org/10.1371/jour
nal.pone.0103499.
22. Thomas DM, Bredlau C, Bosy-Westphal A, Mueller M, Shen W, Gallagher D, et al.Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity (Silver Spring) 2013, 21:2264-2271.https://doi.org/10.1002/oby.20408.
23. Krakauer NY, Krakauer JC.A new body shape index predicts mortality hazard independently of body mass index. PLoS One 2012, 7:e39504.https://doi.org/
10.1371/journal.pone.0039504.
24. Agbim U, Carr RM, Pickett-Blakely O, Dagogo-Jack S.Ethnic Disparities in Adiposity: Focus on Non-alcoholic Fatty Liver Disease, Visceral, and Generalized Obesity. Curr Obes Rep 2019, 8:243-254.https://doi.org/10.1007/s13679-019-00349-x.
25. Li L, Liu DW, Yan HY, Wang ZY, Zhao SH, Wang B.Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev 2016, 17:510-519.https://doi.org/10.1111/obr.12407.
26. Wakabayashi I, Daimon T.The "cardiometabolic index" as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin Chim Acta 2015, 438:274-278.https://doi.org/10.1016/j.cca.2014.08.042.
27. Guerrero-Romero F, Rodrı́guez-Morán M.Abdominal volume index. an anthropometry-based index for estimation of obesity is strongly related to impaired glucose tolerance and type 2 diabetes mellitus. Archives of Medical Research 2003, 34:428-432. https://doi.org/10.1016/s0188-4409(03)00073-0.
28. Tan A, Gao Y, Yang X, Zhang H, Qin X, Mo L, et al.Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey. Metabolism 2011, 60:1186-1192.https://doi.org/10.1016/
j.metabol.2011.01.002.
29. Gao Y, Wang M, Zhang H, Tan A, Yang X, Qin X, et al.Are metabolic syndrome and its components associated with lower urinary tract symptoms? Results from a Chinese male population survey. Urology 2012, 79:194-201. https://doi.org/10.1016/j.urology.2011.07.1399.
30. Liu Z, Ye F, Zhang H, Gao Y, Tan A, Zhang S, et al. The association between the levels of serum ferritin and sex hormones in a large scale of Chinese male population. PLoS One 2013, 8:e75908.https://doi.org/10.1371/journal.pone.
0075908.
31. Ye J, Yao Z, Tan A, Gao Y, Chen Y, Lin X, et al. Low Serum Sex Hormone-Binding Globulin Associated with Insulin Resistance in Men with Nonalcoholic Fatty Liver Disease. Horm Metab Res 2017, 49:359-364.https://doi.org/10.1055/s-0043-102690.
32. Tekin T, Cicek B, Konyaligil N, Gunturk I, Yazici C, Karaca Z, et al. Increased hip circumference in individuals with metabolic syndrome affects serum nesfatin-1 levels. Postgrad Med J 2020, 96:600-605.https://doi.org/10.1136/postgradme
dj-2019-136887.
33. Nishida C, Ko GT, Kumanyika S.Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. Eur J Clin Nutr 2010, 64:2-5.https://doi.org/10.1038/ejcn.2009.139.
34. Tian GX, Sun Y, Pang CJ, Tan AH, Gao Y, Zhang HY,et al.Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men. Obesity Reviews 2012, 13:381-387.https://doi.org/10.1111/j.1467-789X.2011.00978.x.
35. Habib SS, Alkahtani S, Alhussain M, Aljuhani O.Sarcopenia Coexisting with High Adiposity Exacerbates Insulin Resistance and Dyslipidemia in Saudi Adult Men. Diabetes Metab Syndr Obes 2020, 13:3089-3097.https://doi.org/10.2147/
DMSO.S260382.
36. Jung K, Kim J, Park HY, Jung WS, Lim K.Hypoxic Pilates Intervention for Obesity: A Randomized Controlled Trial. Int J Environ Res Public Health 2020, 17.
https://doi.org/10.3390/ijerph17197186.
37. Xie Y, Wang M, Zhang Y, Zhang S, Tan A, Gao Y, et al.Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. PLoS One 2013, 8:e67152.https://doi.org/10.1371/journal.pone.0067152.
38. Shan G.Improved Confidence Intervals for the Youden Index. PLoS One 2015, 10:e0127272. https://doi.org/10.1371/journal.pone.0127272.
39. Seo IH, Lee HB, Kim S, Lee YJ, Jung DH.Inverse Relationship between Hepatic Steatosis and Alanine Aminotransferase with Sex Hormone-Binding Globulin in Men. Yonsei Med J 2017, 58:731-736.https://doi.org/10.3349/ymj.2017.58.4.
731.
40. Wang X, Xie J, Pang J, Zhang H, Chen X, Lin J, et al. Serum SHBG Is Associated With the Development and Regression of Nonalcoholic Fatty Liver Disease: A Prospective Study. J Clin Endocrinol Metab 2020, 105.https://doi.org/10.1210/
clinem/dgz244.
41. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A,et al.The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006, 6:33.https://doi.org/10.1186
/1471-230X-6-33.
42. Ju DY, Choe YG, Cho YK, Shin DS, Yoo SH, Yim SH, et al.The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults. Clin Mol Hepatol 2013, 19:140-147. https://doi.org/10.3350/cmh.2013.19.2.140.
43. Zheng RD, Chen ZR, Chen JN, Lu YH, Chen J.Role of Body Mass Index, Waist-to-Height and Waist-to-Hip Ratio in Prediction of Nonalcoholic Fatty Liver Disease. Gastroenterol Res Pract 2012, 2012:362147.https://doi.org/10.1155/2012/
362147.
44. Yoo HJ, Park MS, Lee CH, Yang SJ, Kim TN, Lim KI, et al.Cutoff points of abdominal obesity indices in screening for non-alcoholic fatty liver disease in Asians. Liver Int 2010, 30:1189-1196.https://doi.org/10.1111/j.1478-3231.
2010.02300.x.
45. Cuthbertson DJ, Weickert MO, Lythgoe D, Sprung VS, Dobson R, Shoajee-Moradie F, et al.External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. Eur J Endocrinol 2014, 171:561-569. https://doi.org/10.1530/EJE-14-0112.
46. Dai H, Wang W, Chen R, Chen Z, Lu Y, Yuan H.Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults. Nutr Metab (Lond) 2017, 14:49. https://doi.org/10.1186/s12986-017-0206-2.
47. Vongsuvanh R, George J, McLeod D, van der Poorten D.Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease. J Hepatol 2012, 57:392-398.https://doi.org/10.1016/j.jhep.2012.03.
013.
48. Rubén DR, María DB, Alicia CF,Tomás GDF , Luis GH, Sara CA,et al.Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients.Rev Esp Enferm Dig 2014, 106:522-528.https://doi.org/PMID:25544409.
49. Ercin CN, Dogru T, Genc H, Celebi G, Aslan F, Gurel H, et al.Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease. Metab Syndr Relat Disord 2015, 13:319-325.https://doi.org/10.1089/met.2015.0018.
50. Petta S, Amato MC, Di Marco VD, Camma C, Pizzolanti G, Barcellona MR,et al.Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2012, 35:238-247.
https://doi.org/10.1111/j.1365-2036.2011.04929.x.
51. Kendel Jovanovic G, Mrakovcic-Sutic I, Pavicic Zezelj S, Susa B, Rahelic D, Klobucar Majanovic S.The Efficacy of an Energy-Restricted Anti-Inflammatory Diet for the Management of Obesity in Younger Adults. Nutrients 2020, 12.
https://doi.org/10.3390/nu12113583.
52. Yang S, Zhao H, Xu K, Qian Y, Wu M, Yang T, et al. Evaluation of common variants in MG53 and the risk of type 2 diabetes and insulin resistance in Han Chinese. Springerplus 2016, 5:612.https://doi.org/10.1186/s40064-016-2218-1.